Warning over risk of Guillain-Barré syndrome following RSV vaccination

The Medicines and Healthcare products Regulatory Agency said that, as of 2 June 2025, it had received 21 Yellow Card reports of suspected Guillain-Barré syndrome in older adults aged 75–79 years after they received the Abrysvo vaccine.…